4,5-Dihydroisoxazole Derivative of Ticagrelor

Product Description
CAT No.
ALN-T023245
CAS No.
NA
Mol. F.
C23H27F2N7O5S
Mol. Wt.
551.6
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (1S,2S,3R,5S)-3-(7-((3-(3,4-difluorophenyl)-4,5-dihydroisoxazol-5-yl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
Smiles : O[C@@H]1[C@H](O)[C@@H](OCCO)C[C@H]1N2N=NC3=C2N=C(SCCC)N=C3NC4ON=C(C5=CC(F)=C(F)C=C5)C4
Technical Data
Reference
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.nFrom World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav – From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42
RFQ